JOHNSON & JOHNSON is expected to release its Q2 2026 10-Q filing in the upcoming earnings season. Last quarter: JNJ delivered strong Q1 FY2026 revenue growth of 9.9% to $24.1B, but net income fell 52.4% to $5.2B, likely driven by elevated SG&A (+18.0%) and one-time charges, while cash and equivalents dropped sharply by 43.6%.
Drawn from management commentary in the Q1 2026 10-Q:
JNJ reported Q1 FY2026 revenue of $24.1B, up 9.9% year-over-year from $21.9B, reflecting broad-based growth across its business segments. Cost of revenue grew at a slightly faster pace of 10.2%, keeping gross margin nearly flat at 66.3%.
Net income fell 52.4% year-over-year to $5.2B from $11.0B in the prior-year period. This significant divergence from revenue growth suggests the presence of substantial one-time charges, litigation settlements, or restructuring costs not captured in the XBRL income statement line items provided.
Selling, General & Administrative expenses rose 18.0% year-over-year to $6.0B from $5.1B, growing nearly twice as fast as revenue. This elevated cost base is a key driver of margin compression and the decline in net income.
Revenue
$24.06B
++9.91% YoY
EPS (Basic)
$2.17
-52.52% YoY
Gross Margin
66.3%
-0.08% YoY
Add JNJ to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.